Stay updated with breaking news from Gene Hung. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the acquisition of all outstanding shares of XinThera, a privately held biotech company in San Diego. The acquisition complements Gilead’s existing clinical development priorities by adding additional pipeline assets for well-validated targets in oncology and ...
– Acquisition of XinThera Provides Gilead with Precision Small Molecules Focused on PARP1 and MK2 Inhibitors – ... | May 9, 2023
San Diego, CA (PRWEB) September 08, 2022 -- XinThera, Inc., a drug discovery company focused on building a small molecule oncology and immunology pipeline,
San Diego, CA (PRWEB) August 22, 2022 -- XinThera, Inc., today announced that Stephen Kaldor, Ph.D., its founder and chairman of its Board of Directors,